<DOC>
	<DOCNO>NCT02909868</DOCNO>
	<brief_summary>The position RV lead may important role effectiveness Programmable Hypertension Control ( PHC ) therapy Moderato pacemaker elicit lag RV signal ( QRS ) identify . The study attempt measure RV Pressure RV Volume PHC two RV lead location .</brief_summary>
	<brief_title>CS-03 Pressure-Volume Loop Sub-study With RV Lead Positioning</brief_title>
	<detailed_description>Subjects find eligible participation CS-03 study , indicate de novo pulse generator implant center participate sub-study 100 % dependent RV pace eligible participation sub-study . Patients receive pacemaker pulse generator exchange 100 % pacemaker dependent may participate . Eligible patient provide Informed Consent specific sub-study patient choose participate , patient ask sign Informed Consent undergo procedure describe . Patients prepare draped Moderato implant procedure detail main CS-03 study protocol . Subjects instrument prior Moderato Pacemaker implant procedure . The position RV lead test two site know elicit shortest QRS duration ( The RV apical septum His region ) . A series three test period Moderato System program deliver predetermine PHC setting follow . Following completion measurement , conductance catheter withdrawn Moderato System implant resume describe CS-03 protocol .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>Subject include CS03 study Subject indicate de novo pulse generator implant Subject exclude CS03 study Subject 100 % dependent RV pacing Subject receive pacemaker pulse generator exchange Subject unwilling provide Informed Consent sub study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>